LUPARTUMAB
UNII WB2X681BC8

Substance Identification & Data

This profile provides standardized clinical and technical data for Lupartumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WB2X681BC8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1640971-88-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WB2X681BC8
CAS Registry Number
1640971-88-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LUPARTUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C170141
National Cancer Institute reference terminology for clinical and research data.
INN ID
10258
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lupartumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUPARTUMAB

Common Names & Synonyms

LUPARTUMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN GPI-ANCHORED CELL SURFACE-ASSOCIATED PROTEIN C4.4A) (HUMAN MONOCLONAL BAY 1112623 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BAY 1112623 LIGHT CHAIN, DIMER

Technical Codes

BAY-1112623

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus